Company / Net Income
Zenas BioPharma, Inc. Net Income History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$377.7M
FY2025
5-year range
-$377.7M / -$37.1M
FY2023-FY2025
Trend
-917.5%
vs FY2024
Sector context
#190 of 216
Health Care
What the data says
Net Income changed -918% YoY in FY2025, a notable deviation from the 2-year average annual change of -459%.
Based on SEC 10-K filings.
-$378M in FY2025.
Declined from -$37M to -$378M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 216This company -$377.7M Sector average $454.3M
▼
-183.1% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 917.5% year-over-year.
- Ranks #190 out of 216 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$377.7M | -917.5% |
| FY2024 | -$37.1M | +0.0% |
| FY2023 | -$37.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026